Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical implementation of polygenic risk scores.

European journal of human genetics : EJHG·2025
Same author

Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Low-level constitutional mosaicism of BRCA1 in two women with young onset ovarian cancer.

Hereditary cancer in clinical practice·2022
Same journal

Prognostic value of the immune-inflammatory indices in osteosarcoma: a systematic review and meta-analysis.

World journal of surgical oncology·2026
Same journal

Prognostic impact of lymph node ratio after suboptimal lymphadenectomy in gastric cancer: a retrospective cohort study with interaction analysis.

World journal of surgical oncology·2026
Same journal

Risk-adapted nodal evaluation in stage IA non-small cell lung cancer: a population-based competing-risk analysis.

World journal of surgical oncology·2026
Same journal

Oncologic outcomes after poly-4-hydroxybutyrate scaffold in post-mastectomy breast reconstruction: a retrospective, multi-center cohort study.

World journal of surgical oncology·2026
Same journal

Impact of reinforced pancreaticojejunostomy with or without tissue adhesive glue modified cyanoacrylate following pancreaticoduodenectomy: a randomized controlled clinical trial.

World journal of surgical oncology·2026
Same journal

Correction: Antitumor efficacy and molecular mechanism of lenvatinib combined with vitamin K2 against hepatocellular carcinoma.

World journal of surgical oncology·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.4K

The Manchester guidelines for contralateral risk-reducing mastectomy.

Narendra Nath Basu1,2, G L Ross3, D G Evans4,5

  • 1Nightingale and Genesis Prevention Centre, University Hospital South Manchester, Southmoor Road, Manchester, M23 9LT, UK. naren_basu@hotmail.com.

World Journal of Surgical Oncology
|August 7, 2015
PubMed
Summary
This summary is machine-generated.

A new protocol helps surgeons counsel women considering contralateral risk-reducing mastectomy (CRRM). It stratifies patients by breast cancer risk, guiding evidence-based recommendations for this complex decision.

More Related Videos

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

4.9K
Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

383

Related Experiment Videos

Last Updated: Apr 5, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.4K
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

4.9K
Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

383

Area of Science:

  • Oncology
  • Surgical Oncology
  • Genetics

Background:

  • Rising rates of contralateral risk-reducing mastectomy (CRRM) contrast with decreasing contralateral breast cancer incidence.
  • Surgeons exhibit variable practices in CRRM recommendations.
  • Existing protocols lack comprehensive risk stratification for CRRM.

Purpose of the Study:

  • To develop a standardized protocol for evaluating patients considering CRRM.
  • To provide evidence-based guidelines for CRRM decision-making.
  • To address the complexity of patient motivations for CRRM.

Main Methods:

  • Systematic literature review on contralateral breast cancer risk factors.
  • National UK survey of surgical practices.
  • Development of a 5-step CRRM assessment protocol.
  • Multi-disciplinary team (MDT) formulation of guidelines.

Main Results:

  • A novel formula for calculating lifetime contralateral breast cancer risk was devised.
  • Patients are stratified into low, above average, moderate, and high-risk groups.
  • Risk stratification enables tailored recommendations for CRRM.

Conclusions:

  • The developed guidelines offer a valuable tool for clinicians counseling women on CRRM.
  • Mandatory risk assessment is crucial for patients requesting CRRM.
  • The new formula supports evidence-based recommendations in CRRM consultations.